Gao Kai, Oerlemans Rick, Groves Matthew R
Structure Biology in Drug Design, Drug Design Group XB20, Departments of Pharmacy, University of Groningen, Groningen, The Netherlands.
Biophys Rev. 2020 Feb;12(1):85-104. doi: 10.1007/s12551-020-00619-2. Epub 2020 Jan 31.
Differential scanning fluorimetry (DSF) is an accessible, rapid, and economical biophysical technique that has seen many applications over the years, ranging from protein folding state detection to the identification of ligands that bind to the target protein. In this review, we discuss the theory, applications, and limitations of DSF, including the latest applications of DSF by ourselves and other researchers. We show that DSF is a powerful high-throughput tool in early drug discovery efforts. We place DSF in the context of other biophysical methods frequently used in drug discovery and highlight their benefits and downsides. We illustrate the uses of DSF in protein buffer optimization for stability, refolding, and crystallization purposes and provide several examples of each. We also show the use of DSF in a more downstream application, where it is used as an in vivo validation tool of ligand-target interaction in cell assays. Although DSF is a potent tool in buffer optimization and large chemical library screens when it comes to ligand-binding validation and optimization, orthogonal techniques are recommended as DSF is prone to false positives and negatives.
差示扫描荧光法(DSF)是一种易于使用、快速且经济的生物物理技术,多年来已得到广泛应用,从蛋白质折叠状态检测到与目标蛋白结合的配体鉴定。在本综述中,我们讨论了DSF的理论、应用和局限性,包括我们自己以及其他研究人员对DSF的最新应用。我们表明,DSF是早期药物发现工作中一种强大的高通量工具。我们将DSF与药物发现中常用的其他生物物理方法进行了比较,并突出了它们的优缺点。我们阐述了DSF在用于蛋白质稳定性、重折叠和结晶的缓冲液优化中的用途,并分别提供了几个示例。我们还展示了DSF在更下游应用中的使用,即在细胞实验中用作配体-靶点相互作用的体内验证工具。尽管在配体结合验证和优化方面,DSF在缓冲液优化和大型化学文库筛选中是一种有效的工具,但由于DSF容易出现假阳性和假阴性,因此建议使用正交技术。